Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1743studies shown
Showing 325-336 of 1,743
Drug study icon
CompletedEUCTR 2006-001529-24

Adults adminstered Venlafaxine and Eszopiclone Response to Treatment (AVERT): A 31-Week, Efficacy, Safety and Tolerability Study of Eszopiclone 3 mg Co-administered with Venlafaxine in Subjects wit...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
DepressionDrugA study involving a medication or substance.
Countries
France, United Kingdom, Austria, ...
Sponsor
Sepracor NV in care of Sepracor Inc.
Condition
Depression
Other study type icon
CompletedNCT04474444

Ambulance Calls for Substance Use and Alcohol in a Pandemic (ASAP)

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom
AddictionObservationalA study where researchers collect information without assigning a treatment.
Countries
United Kingdom
Sponsor
University of Lincoln
Condition
Addiction
Other study type icon
Active Not RecruitingNCT05905003

AMP SCZ® Observational Study: PREDICT-DPACC

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom
SchizophreniaObservationalFrom 12 Years to 30 Years
Countries
United States, Australia, Canada, ...
Sponsor
Brigham and Women's Hospital
Condition
Schizophrenia
Drug study icon
CompletedEUCTR 2004-001500-13

An 8-week, multicentre, randomised, double-blind, placebo-controlled, flexible dose study of Pregabalin (300-600 mg/day) and Venlafaxine XR (75-225 mg/day) for the acute treatment of DSM-IV General...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
AnxietyDrug
Countries
United Kingdom, Ireland, Italy, ...
Sponsor
Pfizer Ltd.
Condition
Anxiety
Drug study icon
CompletedNCT02473289

Sirukumab for depression

This study is completed in the United States, in Canada, in the United Kingdom, .... It is testing sirukumab for depression.

In United Kingdom
DepressionDrugFrom 21 Years to 64 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT02498392

Safety study of JNJ-42165279 in depression

This study is completed in the United States, in the United Kingdom, in Moldova, .... It is testing JNJ-42165279 for depression.

In United Kingdom
Depression, AnxietyDrugFrom 18 Years to 64 Years
Countries
United States, United Kingdom, Moldova, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression, Anxiety
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.